MedPath

Sexuality after breast cancer - A study of the sexual health of patients and their partners

Conditions
Sexual Health after Breast Cancer
Registration Number
DRKS00032420
Lead Sponsor
Klinik und Poliklinik für Geburtshilfe und Frauengesundheit der Universitätsmedizin Mainz
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
128
Inclusion Criteria

Arm 1: female sex, history of breast cancer, primary therapy (surgery, radiotherapy, chemotherapy) completed within 5 years prior to treatment initiation, current partnership, age between 18 and 80 years.

Arm 2: all sexes, current partnership with patient from Arm 1, no breast cancer in medical history, age over 18 years

Exclusion Criteria

Arm 1: male sex, ongoing primary therapy (surgery, radiotherapy, chemotherapy), no current partnership, age less than 18 or greater than 80 years

Arm 2: medical history of breast cancer, age less than 18 years.

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The aim of the present work is to investigate the sexual health of breast cancer patients and their partners. <br>The following endpoints will be investigated: <br>1. sexual satisfaction (EORTC Sexual Health Questionnaire (SHQ-22))<br>2. sexual functioning (EORTC Sexual Health Questionnaire (SHQ-22))<br>3. erectile functioning in the collective of male partners (Erectile Function Domaine des IIEF)<br>4. subjectively perceived change in satisfaction with partner sexuality before and since diagnosis? (Question (2) of the questionnaire see above).<br>5. need for information regarding possible changes in sexuality in the context of breast cancer and its therapy? (Questionnaire on sexual health care (5) see above).<br><br>The parameters will be checked once in the period of up to 5 years after the end of the breast cancer therapy (surgery, chemotherapy, radiation), anti-hormone therapies and/or targeted therapies do not have to be finished at the time of study participation.
Secondary Outcome Measures
NameTimeMethod
Depression symptoms (PHQ-9) <br><br>Impact of the COVID-19 pandemic on partnership and sexuality (single question assessing the subjectively perceived impact of the pandemic on sexuality and partnership).<br><br>Subgroup analyses
© Copyright 2025. All Rights Reserved by MedPath